The HCM Academy 2023 primary care webinar series concluded this month.
Brought to you by PCM Scientific, our CME division, the series benefitted from the input of six expert faculty from the US and Europe who lead the field in treatment of hypertrophic cardiomyopathy (HCM).
The aim of the HCM Academy 2023 primary care series was to raise overall awareness of HCM in professionals who work outside the cardiology setting and highlight how the presence of HCM can impact other areas of patient care that are relevant in the primary care setting.
The topics covered included identification of HCM and how it might present in a primary care setting, the role of HCM in development of arrhythmias and how treatment of arrhythmias can impact other treatment decisions, and the impact of HCM on patient ability to exercise and how HCM can impact on pregnancy.
All live webinars from the HCM Academy 2023 primary care series were delivered twice to allow attendees the opportunity to join at a time convenient to their time zone.
The programme was available to primary audiences including GPs and nurses, across the United States, Canada, and Europe, including the United Kingdom. Marketing was done via the HCM Academy, and our media brands, Pulse and Nursing in Practice.
The feedback from learners has been overwhelmingly positive, with an average satisfaction rating of 4.9 out of 5, and many positive reviews of the content.
“Excellent presentation with easy to understand and remember the key messages”,
“Excellent webinar, relatable and enjoyable. Case studies always help put things into focus”.
Results so far show significant improvements from pre-learning assessment scores to post-learning assessment scores, with an average gain in competence of 27% and an average gain in knowledge of 33%.
The complete HCM Academy primary care series is now available on-demand on the HCM Academy website and healthcare professionals can gain three CME credits for completing the series.